Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy
<p>Abstract</p> <p>Background</p> <p>Phagocytosis of apoptotic cells by macrophages induces a suppressor phenotype. Previous data from our group suggested that this occurs via Platelet-activating factor receptor (PAF-R)-mediated pathways. In the present study, we invest...
Main Authors: | Rohde Ciro BS, Pinheiro Mônica C, Fernandes Patrícia D, Nonogaki Sueli, Onuchic Ana C, Andrade Luciana NS, de Oliveira Soraya I, Chammas Roger, Jancar Sonia |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-05-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/200 |
Similar Items
-
Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF
by: Vyala Hanumanthareddy Chaithra, et al.
Published: (2018-11-01) -
Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy
by: Ildefonso Alves da Silva Junior, et al.
Published: (2018-10-01) -
Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesiss⃞
by: Jiawei Chen, et al.
Published: (2007-11-01) -
Paf-Metabolic Enzymes and Paf-like Activity in and Promastigotes
by: P. Chatzovoulos, et al.
Published: (2011-09-01) -
Teratoid Wilms tumour with chemotherapy resistance
by: Renuka Gahine, et al.
Published: (2015-01-01)